Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04712656 · ClinicalTrials.gov registry record
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
A clinical trial of Sleep Apnea, Obstructive, sponsored by Ohio State University.
- Recruiting
- Registry status
- 1,739
- Enrollment target
- 1
- Study location
NCT04712656 is a study of Sleep Apnea, Obstructive that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 1,739 participants, above the 224-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (676% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04712656, a study of Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 1,739 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.
Conditions Studied
Interventions
- DEVICE CPAP therapy
Study Locations (1)
Ohio
- Martha Morehouse Medical Pavilion, Suite 2600 - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,739 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2032-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04712656
The ClinicalTrials.gov registry entry for NCT04712656 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,739 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 224-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (676% higher). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which CPAP therapy is the first listed.
NCT04712656 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04712656 about?
NCT04712656 is a clinical study titled "Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea". The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.
What is the current status of trial NCT04712656?
This trial is currently recruiting. The enrollment target is 1,739 participants. The study started on 2021-03-22. Estimated completion is 2032-03-01.
What conditions does trial NCT04712656 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
What interventions are being tested in trial NCT04712656?
The interventions under investigation include: CPAP therapy (DEVICE).
Who is sponsoring clinical trial NCT04712656?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04712656 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
-
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RECRUITING · Phase 3
-
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.